OmniAb, Inc. Common Stock (OABI)
OmniAb, Inc. is a biotechnology company focused on developing and licensing innovative antibody discovery platforms. The company’s technology enables the creation of next-generation therapeutic antibodies, primarily serving the biopharmaceutical industry in drug discovery and development.
Company News
AI is transforming healthcare through innovative technologies like disease screening, genetic testing, antibody discovery, and drug development platforms, with several companies making significant technological advancements in medical AI applications.
VERAXA Biotech and OmniAb have entered a co-discovery alliance to develop a novel bispecific antibody drug conjugate program targeting solid tumors. The partnership combines VERAXA's ADC technology with OmniAb's antibody discovery solutions.
USANA Health (USNA) delivered earnings and revenue surprises of 24.64% and 2.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Penny stocks to buy according to 7 insiders in May 2023. The post 7 Hot Penny Stocks To Buy In May According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.